- Home
- VRDN vs IMAX Comparison
VRDN vs IMAX Comparison
Compare VRDN & IMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- IMAX
- Stock Information
- Founded
- VRDN 2006
- IMAX 1967
- Country
- VRDN United States
- IMAX Canada
- Employees
- VRDN N/A
- IMAX N/A
- Industry
- VRDN Medical Specialities
- IMAX
- Sector
- VRDN Health Care
- IMAX
- Exchange
- VRDN Nasdaq
- IMAX Nasdaq
- Market Cap
- VRDN 1.6B
- IMAX 1.4B
- IPO Year
- VRDN N/A
- IMAX 1994
- Fundamental
- Price
- VRDN $19.72
- IMAX $25.65
- Analyst Decision
- VRDN Strong Buy
- IMAX Buy
- Analyst Count
- VRDN 11
- IMAX 10
- Target Price
- VRDN $37.63
- IMAX $25.30
- AVG Volume (30 Days)
- VRDN 1.4M
- IMAX 545.1K
- Earning Date
- VRDN 11-12-2024
- IMAX 10-30-2024
- Dividend Yield
- VRDN N/A
- IMAX N/A
- EPS Growth
- VRDN N/A
- IMAX N/A
- EPS
- VRDN N/A
- IMAX 0.44
- Revenue
- VRDN $302,000.00
- IMAX $345,554,000.00
- Revenue This Year
- VRDN $2.55
- IMAX $2.89
- Revenue Next Year
- VRDN N/A
- IMAX $10.30
- P/E Ratio
- VRDN N/A
- IMAX $56.90
- Revenue Growth
- VRDN N/A
- IMAX N/A
- 52 Week Low
- VRDN $11.40
- IMAX $13.20
- 52 Week High
- VRDN $27.20
- IMAX $26.84
- Technical
- Relative Strength Index (RSI)
- VRDN 49.14
- IMAX 55.51
- Support Level
- VRDN $20.06
- IMAX $24.67
- Resistance Level
- VRDN $23.65
- IMAX $26.42
- Average True Range (ATR)
- VRDN 1.05
- IMAX 0.71
- MACD
- VRDN 0.16
- IMAX -0.20
- Stochastic Oscillator
- VRDN 49.45
- IMAX 43.09
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.
About IMAX Imax Corporation
Imax Corp is a premier global technology platform for entertainment and events. Through its proprietary software, auditorium architecture, patented intellectual property, and specialized equipment, IMAX offers a unique end-to-end solution to create superior, immersive content experiences for which the IMAX brand is globally renowned. Top filmmakers, movie studios, artists, and creators utilize the cutting-edge visual and sound technology of IMAX to connect with audiences in innovative ways. The Company leverages its proprietary technology and engineering in all aspects of its business, which principally consists of the IMAX film remastering and the sale or lease of premium IMAX theater systems.